Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2002-08-16
2010-10-12
Mondesi, Robert (Department: 1645)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S130100, C424S133100, C424S139100, C424S141100
Reexamination Certificate
active
07811569
ABSTRACT:
The present invention relates to a recombinant human antibody comprising an antibodysequence specific for the MSP-3 antigen ofPlasmodium falciparum. In particular, the invention relates to a recombinant human antibody which is specific for the MSP-3194-257antigen. The invention further relates to nucleic acid encoding such antibodies and to uses of these antibodies, in particular in the treatment or prophylaxis of malaria.
REFERENCES:
patent: 4897354 (1990-01-01), Siddiqui
patent: 6017538 (2000-01-01), Druilhe et al.
patent: 6114598 (2000-09-01), Kucherlapati et al.
patent: 6949627 (2005-09-01), Druilhe et al.
patent: WO 9211383 (1992-07-01), None
patent: WO 9605229 (1996-02-01), None
patent: WO 96/37234 (1996-11-01), None
patent: WO 0012562 (2000-03-01), None
patent: WO 00/20460 (2000-04-01), None
patent: WO01/36587 (2001-05-01), None
Badell Edgar et al: “Human malaria in immunocompromised mice: An in vivo model to study defense mechanisms againstPlasmodium falciparum.” Journal of Experimental Medicine, vol. 192, No. 11, Dec. 4, 2000, pp. 1653-1659.
Paul, William E. Fundamental Immunology, 3rd Edition, 1993, Raven Press, New York, pp. 292-295.
Rudikoff et al. Proc. Natl. Acad. Sci. USA 1982 vol. 79: p. 1979-1983.
Abbas et al. Cellular and Molecular Immunology 4th edition, 2000, p. 42-43, 48, 55 and 477.
Goni et al. J. Immunology 142:3158-3163, 1989.
Sequence alignment—7 pages.
Bendig et al Methods: A companion to Methods in Enzymology vol. 8 pp. 83, 85, 87,89,91 and 93 (1995).
Badell, E. et al., “Human Malaria in Immunocompromised Mice: An In Vivo Model to Study Defense Mechanisms AgainstPlasmodium falciparum”, Journal of Experimental Medicine, vol. 192, No. 11, pp. 1653-1659, (Dec. 4, 2000).
Oeuvray, C. et al., “A Novel Merozoite Surface Antigen ofPlasmodium falciparum(MSP-3) Identified by Cellular-Antibody Cooperative Mechanism Antigenicity and Biological Activity of Antibodies”, Memorias Do Instituto Oswaldo Cruz, Rio De Janeiro, BR, vol. 89, No. Supp. II, pp. 77-80, (1994).
Oeuvray, C. et al., “Merozoite Surface Protein-3: A Malaria Protein Inducing Antibodies That PromotePlasmodium falciparumKilling by Cooperation With Blood Monocytes”, Blood, vol. 84, No. 5, pp. 1594-1602, (Sep. 1, 1994).
De Haard, H. J. et al., “A Large Non-Immunized Human Fab Fragment Phage Library That Permits Rapid Isolation and Kinetic Analysis of High Affinity Antibodies”, Journal of Biological Chemistry, American Society of Biological Chemists, vol. 274, No. 26, pp. 18218-18230, (Jun. 25, 1999).
Roeffen, W. F. G. et al., “Recombinant Human Antibodies Specific for the Pfs48/45 Protein of the Malaria ParasitePlasmodium falciparum”, Journal of Biological Chemistry, vol. 276, No. 23, pp. 19807-19811, (Jun. 8, 2001).
Dziegiel et al., “Recombinant human antibodies against the Plasmodium falciparum glutamate rich protein,” Immunotechnology vol. 2(4), 1996, p. 299.
Sylvester et al., “Construction and in vitro characterization of a humanized monoclonal antibody against Plasmodium falciparum sporozoites,” J. Cell. Biol. (Suppl.) 18D, 1994.
Druilhe Pierre
Dziegiel Morten Steen Hanefeld
Lundquist Rasmus
Nielsen Leif Kofoed
Finnegan Henderson Farabow Garrett & Dunner LLP
Institut Pasteur
Mondesi Robert
Ogunbiyi Oluwatosin
LandOfFree
Recombinant anti- Plasmodium falciparum antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant anti- Plasmodium falciparum antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant anti- Plasmodium falciparum antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4167986